首页> 外文OA文献 >Differential contribution of two serine residues of wild type and constitutively active β2-adrenoceptors to the interaction with β2-selective agonists
【2h】

Differential contribution of two serine residues of wild type and constitutively active β2-adrenoceptors to the interaction with β2-selective agonists

机译:两个野生型和组成型活性β2肾上腺素受体的丝氨酸残基对与β2选择性激动剂相互作用的不同贡献

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have studied the difference in receptor binding activity between partial and full β2-adrenoceptor agonists and the abilities of the agonists to interact with Ser204 and Ser207 in the fifth transmembrane region of the β2-adrenoceptor, amino acid residues that are important for activation of the β2-adrenoceptor.In the binding study with [125I]-iodocyanopindolol, the Ki values of (±)-salbutamol, (±)-salmeterol, TA-2005 and (−)-isoprenaline for the β2-adrenoceptor expressed in COS-7 cell membranes were 3340, 21.0, 12.0 and 904 nM, respectively. The β1/β2 selectivity of these agonists was in the order of (±)-salmeterol (332 fold)>TA-2005 (52.8)>(±)-salbutamol (6.8)>(−)-isoprenaline (1.1), and the β3-/β2-adrenoceptor selectivity of these agonists was in the order of TA-2005 (150 fold)>(±)-salmeterol (88.6)>(±)-salbutamol (10.4)>(−)-isoprenaline (3.2).The maximal activation of adenylyl cyclase by stimulation of the β1-, β2- and β3-adrenoceptors by TA-2005 was 32, 100 and 100% of that by (−)-isoprenaline, respectively, indicating that TA-2005 is a full agonist at the β2- and β3-adrenoceptors and a partial agonist at the β1-adrenoceptor. (±)-Salbutamol and (±)-salmeterol were partial agonists at both β1- (8% and 9% of (−)-isoprenaline) and β2- (83% and 74% of (−)-isoprenaline) adrenoceptors.The affinities of full agonists, TA-2005 and (−)-isoprenaline, were markedly decreased by substitution of Ala for Ser204 (S204A) of the β2-adrenoceptor, whereas this substitution slightly reduced the affinities of partial agonists, (±)-salbutamol and (±)-salmeterol. Although the affinities of full agonists for the S207A-β2-adrenoceptor were decreased, those of partial agonists for the S207A-β2-adrenoceptor were essentially the same as for the wild type receptor.The constitutively active mutant (L266S, L272A) of the β2-adrenoceptor had an increased affinity for all four agonists. The affinities of full agonists were decreased by substitution of Ser204 of the constitutively active mutant, whereas the degree of decrease was smaller than that caused by the substitution of the wild type receptor. Although the affinities of (±)-salbutamol and (±)-salmeterol for the S207A-β2-adrenoceptor were essentially the same as those for the wild type β2-adrenoceptor, the affinities of (±)-salbutamol and (±)-salmeterol for the constitutively active β2-adrenoceptor were decreased by substitution of Ser207.These results suggest that Ser204 and Ser207 of the wild type and constitutively active β2-adrenoceptors differentially interacted with β2-selective agonists.
机译:我们已经研究了部分和完全β2-肾上腺素受体激动剂之间受体结合活性的差异,以及激动剂与β2-肾上腺素受体第五跨膜区域中Ser204和Ser207相互作用的能力,这些氨基酸残基对于激活β2肾上腺素很重要。 β2-肾上腺素受体。在与[125I]-碘氰基吲哚醇的结合研究中,COS-7中表达的β2-肾上腺素受体的(±)-沙丁胺醇,(±)-沙美特尔,TA-2005和(-)-异肾上腺素的Ki值细胞膜分别为3340、21.0、12.0和904 nM。这些激动剂的β1/β2选择性依次为(±)-沙美特罗(332倍)> TA-2005(52.8)>(±)-沙丁胺醇(6.8)>(-)-异丙肾上腺素(1.1)。这些激动剂的β3-/β2-肾上腺素受体选择性的顺序为TA-2005(150倍)>(±)-沙美特罗(88.6)>(±)-沙丁胺醇(10.4)>(-)-异丙肾上腺素(3.2)。 TA-2005刺激β1-,β2-和β3-肾上腺素能受体对腺苷酸环化酶的最大活化作用分别是(-)-异戊二烯那酸的32、100和100%,表明TA-2005是完全激动剂在β2-和β3-肾上腺素受体上是β-受体激动剂,而在β1-肾上腺素受体上是部分激动剂。 (±)-沙丁胺醇和(±)-沙美特罗在β1-(肾上腺素(-)-异丙肾上腺素的8%和9%)和β2-(肾上腺素-(-)-异丙肾上腺素的83%和74%)处都是部分激动剂。通过用Ala替代β2-肾上腺素能受体的Ser204(S204A),完全激动剂TA-2005和(-)-异丙肾上腺素的亲和力显着降低,而这种取代略微降低了部分激动剂(±)-沙丁胺醇和(±)-沙美特罗。尽管完全激动剂对S207A-β2-肾上腺素受体的亲和力降低了,但部分激动剂对S207A-β2-肾上腺素受体的亲和力与野生型受体基本相同.β2的组成型活性突变体(L266S,L272A) -肾上腺素能受体对所有四种激动剂的亲和力均增加。完全激动剂的亲和力通过取代组成型活性突变体的Ser204而降低,而降低的程度小于由野生型受体的取代引起的降低。尽管(±)-沙丁胺醇和(±)-沙美特罗对S207A-β2-肾上腺素受体的亲和力与野生型β2-肾上腺素受体的亲和力基本相同,但(±)-沙丁胺醇和(±)-沙美特罗的亲和力结果表明,野生型的Ser204和Ser207以及组成型活性的β2-肾上腺素受体与β2-选择性激动剂之间存在差异性相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号